Stay updated on Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.

Latest updates to the Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2.SummaryDifference0.0%

- Check26 days agoChange DetectedBanner announcing a government funding lapse was removed from the page; core study details, contacts, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check49 days agoChange DetectedThe new screenshot shows minor UI/formatting changes to the Study Details page; core data and criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check77 days agoChange DetectedVersion update from v3.0.2 to v3.1.0; no substantive content changes identified.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1; the 'Back to Top' link was removed. No other substantive content changes were detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.